Is it a real risk to take ciprofloxacin? [8]

Plastic and Reconstructive Surgery

Volumn 114, Issue 1, 2004, Pages 267-

  Fama, Umberto ^a,b   Irace, Silvio ^a   Frati, Riccardo ^a   De Gado, Federico ^a   Scuderi, Nicolò ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; IMIPENEM; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STEROID; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACHILLES TENDON; ADULT; ANTHRAX; ANTIBIOTIC PROPHYLAXIS; CASE REPORT; HUMAN; LETTER; MUSCULOSKELETAL DISEASE; PRIORITY JOURNAL; RISK FACTOR; TENDINITIS; TENDON DISEASE; TENDON RUPTURE; TENOSYNOVITIS; CHEMICALLY INDUCED DISORDER; MALE;

ADULT; ANTHRAX; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; HUMANS; MALE; MUSCULOSKELETAL DISEASES; TENDINOPATHY;

EID: 4444249829     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000127238.45551.12     Document Type: Letter

References (10)

1. Royer, R. J., Pierfitte, C., and Netter, P. Features of tendon disorders with fluoroquinolones. Therapie 49: 75, 1994.
2. Huston, K. A. Achilles tendinitis and tendon rupture due to fluoroquinolone antibiotics. N. Engl. J. Med. 331: 748, 1994.
3. Williams, R. J., III, Attia, E., Wickiewicz, T. L., and Hannafin, J. A. The effect of ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism. Am. J. Sports Med. 28: 364, 2000.
4. World Health Organization Data Bank. December 18, 2001.
5. Zabraniecki, L., Negrier, I., Vergne, P., et al. Fluoroquinolone induced tendinopathy: Report of 6 cases. J. Rheumatol. 23: 516, 1996.
6. Malaguti, M., Triolo, L., and Biagini, M. Ciprofloxacin-associated Achilles tendon rupture in a hemodialysis patients. J. Nephrol 14: 431, 2001.
7. Ribard, P., Audisio, F., Khan, M. F., et al. Seven Achilles tendonitis including 3 complicated by rupture during fluoroquinolone therapy. J. Rheumatol. 19: 1479, 1992.
8. Van der Linden, P. D., Van Puijenbroek, E. P., Feenstra, J., et al. Tendon disorders attributed to fluoroquinolones: A study on 42 spontaneous reports in the period 1988 to 1998. Arthritis Rheum. 45: 235, 2001.
9. U.S. Food and Drug Administration. October 18, 2001 (Bayer, October 21, 2001).
10. Brook, I. The prophylaxis and treatment of anthrax. Int. J. Antimicrob. Agents 20: 320, 2002.